Literature DB >> 1413842

Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension.

J J Sancho1, J Rouco, R Riera-Vidal, A Sitges-Serra.   

Abstract

The prevalence of arterial hypertension in primary hyperparathyroidism (PHPT) is higher than in the general population. With the aim of determining the evolution of hypertension associated with PHPT, we analyzed a group of 56 patients followed for a mean of 60 months (range 10-101 months) after successful parathyroidectomy for PHPT. The study group consisted of 16 men and 40 women. The mean age was 49 +/- 12 years (range 18-73 years). None of the patients had renal impairment. Two hypertensive patients died during the follow-up from complications related to their hypertension. Twelve (21.8%) patients were hypertensive before parathyroid surgery (systolic greater than 160 mmHg and/or diastolic greater than 90 mmHg). Pre-operative midregion serum parathyroid hormone concentration was higher in the hypertensive patients than in normotensive patients (2.7 +/- 2.4 vs 0.82 +/- 0.4 mu iEq/l, p = 0.018). Pre-operative creatinine clearance was lower in the hypertensive patients than in normotensive patients (65.4 +/- 27.5 vs 86.7 +/- 26 ml/min, p = 0.002). There were no significant differences between normotensive and hypertensive patients in age, sex, body weight, clinical manifestations, weight of parathyroid tissue removed, and calcium metabolism, or in plasma concentrations of magnesium, uric acid, cholesterol, proteins, or albumin. During follow-up, none of the patients with pre-operative hypertension became normotensive, whereas 32% of the patients who were normotensive preoperatively developed clinical hypertension. The global prevalence of postoperative hypertension was thus 48%. The patients that developed hypertension after parathyroidectomy were followed for a longer period than the normotensive patients (76 +/- 17 vs 53 +/- 10 months, p = 0.005), had a lower postoperative creatinine clearance (74 +/- 28 vs 90 +/- 25 mg/min, p = 0.07), and higher cholesterol levels (6.2 +/- 1.5 vs 5.5 +/- 0.9 mmol/L, p = 0.08).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1413842     DOI: 10.1007/bf02067371

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Arterial hypertension and primary hyperparathyroidism. Incidence and follow-up after parathyroidectomy.

Authors:  A Rapado
Journal:  Am J Nephrol       Date:  1986       Impact factor: 3.754

2.  Clinical and biochemical features in primary hyperparathyroidism.

Authors:  M T Nikkilä; J J Saaristo; T A Koivula
Journal:  Surgery       Date:  1989-02       Impact factor: 3.982

3.  Clinical correlates in parathyroid hypertension.

Authors:  R Maheswaran; D G Beevers
Journal:  J Hypertens Suppl       Date:  1989-12

4.  Hormone, calcium and blood pressure relationships in primary hyperparathyroidism.

Authors:  A M Richards; E A Espiner; M G Nicholls; H Ikram; E J Hamilton; A H Maslowski
Journal:  J Hypertens       Date:  1988-09       Impact factor: 4.844

5.  Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism.

Authors:  A F Dominiczak; F Lyall; J J Morton; H J Dargie; I T Boyle; T T Tune; G Murray; P F Semple
Journal:  Clin Sci (Lond)       Date:  1990-02       Impact factor: 6.124

6.  Primary hyperparathyroidism. A review of the long-term surgical and nonsurgical morbidities as a basis for a rational approach to treatment.

Authors:  F W Lafferty; C A Hubay
Journal:  Arch Intern Med       Date:  1989-04

7.  Chronic continuous PTH infusion results in hypertension in normal subjects.

Authors:  H N Hulter; J C Melby; J C Peterson; C R Cooke
Journal:  J Clin Hypertens       Date:  1986-12       Impact factor: 3.738

8.  Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy.

Authors:  P D Broulik; K Horký; V Pacovský
Journal:  Exp Clin Endocrinol       Date:  1985-12

9.  Is parathyroidectomy of benefit in primary hyperparathyroidism?

Authors:  S Posen; P Clifton-Bligh; T S Reeve; C Wagstaffe; M Wilkinson
Journal:  Q J Med       Date:  1985-03

10.  Hypercalcemia: long-term follow-up with matched controls.

Authors:  H Rubinoff; N McCarthy; R A Hiatt
Journal:  J Chronic Dis       Date:  1983
View more
  10 in total

1.  Parathyroid hormone reflects adiposity and cardiometabolic indices but not bone density in normal men.

Authors:  Emma O Billington; Greg D Gamble; Ian R Reid
Journal:  Bonekey Rep       Date:  2016-12-07

Review 2.  Current pharmacological options for the management of primary hyperparathyroidism.

Authors:  Peter Vestergaard
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Cardiovascular aspects of primary hyperparathyroidism.

Authors:  M D Walker; S J Silverberg
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

4.  The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis.

Authors:  Maryam Yavari; Awat Feizi; Fahimeh Haghighatdoost; Azin Ghaffari; Hassan Rezvanian
Journal:  Endocrine       Date:  2020-10-15       Impact factor: 3.633

Review 5.  Primary hyperparathyroidism and hypertension.

Authors:  Sarah B Fisher; Nancy D Perrier
Journal:  Gland Surg       Date:  2020-02

Review 6.  Parathyroid hormone and the cardiovascular system.

Authors:  Lorraine A Fitzpatrick; John P Bilezikian; Shonni J Silverberg
Journal:  Curr Osteoporos Rep       Date:  2008-06       Impact factor: 5.096

7.  Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism.

Authors:  Peter Vestergaard; Leif Mosekilde
Journal:  BMJ       Date:  2003-09-06

8.  Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism.

Authors:  P D Broulik; A Brouliková; S Adámek; P Libanský; J Tvrdoň; K Broulikova; J Kubinyi
Journal:  Int J Endocrinol       Date:  2011-02-20       Impact factor: 3.257

9.  Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion.

Authors:  Sarah Zaheer; Jenifer M Brown; Molly Connors; Jonathan S Williams; Gail K Adler; Anand Vaidya
Journal:  Int J Endocrinol       Date:  2017-07-20       Impact factor: 3.257

10.  Parathyroidectomy Ameliorates Glucose and Blood Pressure Control in a Patient with Primary Hyperparathyroidism, Type 2 Diabetes, and Hypertension.

Authors:  Alok Kumar; Sunita Singh
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2015-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.